With the growing prevalence of chronic diseases and an aging population worldwide, a significant surge in critical medical needs should drive the biotech industry’s growth and expansion. Further, supportive government initiatives and funding combined with the growing adoption of advanced digital technologies should boost the industry’s prospects.
Given the solid footing of the industry, it could be wise to invest in fundamentally strong biotech stocks Shionogi & Co., Ltd. (SGIOY), United Therapeutics Corporation (UTHR), and Corcept Therapeutics Incorporated (CORT) for potential gains.
